Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

549
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
549
Drug Therapy01:28

Drug Therapy

242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
242
Long-term Potentiation01:25

Long-term Potentiation

3.4K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

771
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
771
Long-term Depression01:03

Long-term Depression

3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2024
Same author

Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report.

BMC psychiatry·2024
Same author

Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights.

Neuropsychiatric disease and treatment·2023
Same author

Limited clinical validity of univariate resting-state EEG markers for classifying seizure disorders.

Brain communications·2023
Same author

The effect of a low-calorie diet on depressive symptoms in individuals with overweight or obesity: a systematic review and meta-analysis of interventional studies.

Psychological medicine·2023
Same author

Mood and anxiety disorders: a challenge for mental healthcare systems in a changing world.

Current opinion in psychiatry·2023

Related Experiment Video

Updated: Jan 15, 2026

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.2K

Lithium: Old Drug, New tricks?

Rebecca Strawbridge1, Christiana Boules2, Richard Morriss3

  • 1Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Becci.strawbridge@kcl.ac.uk.

Current Psychiatry Reports
|October 14, 2025
PubMed
Summary

Optimizing lithium therapy involves balancing benefits and harms. Strategies include managing side effects, exploring sub-therapeutic doses, and careful monitoring to maintain the lowest effective lithium level for each patient.

Keywords:
Adverse effectsDoseEffectivenessLithiumMonitoringSafetyTitration

More Related Videos

Characterization of Electrode Materials for Lithium Ion and Sodium Ion Batteries Using Synchrotron Radiation Techniques
10:03

Characterization of Electrode Materials for Lithium Ion and Sodium Ion Batteries Using Synchrotron Radiation Techniques

Published on: November 11, 2013

26.0K
Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications
05:33

Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications

Published on: August 12, 2013

22.2K

Related Experiment Videos

Last Updated: Jan 15, 2026

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.2K
Characterization of Electrode Materials for Lithium Ion and Sodium Ion Batteries Using Synchrotron Radiation Techniques
10:03

Characterization of Electrode Materials for Lithium Ion and Sodium Ion Batteries Using Synchrotron Radiation Techniques

Published on: November 11, 2013

26.0K
Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications
05:33

Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications

Published on: August 12, 2013

22.2K

Area of Science:

  • Pharmacology
  • Clinical Therapeutics
  • Psychiatry

Background:

  • Lithium therapy presents a complex clinical challenge due to its significant benefits and potential harms.
  • Effective management requires strategies to maximize therapeutic effects while minimizing adverse events.

Purpose of the Study:

  • To review five potential strategies for optimizing lithium therapy.
  • To enhance the benefit-to-harm ratio of lithium treatment.

Main Methods:

  • Review of existing evidence on lithium therapy optimization strategies.
  • Analysis of long-standing evidence for adverse effect management.
  • Examination of emerging research on sub-therapeutic lithium doses.
  • Consideration of gradual titration, variable dosing, and enhanced monitoring techniques.

Main Results:

  • Evidence for optimizing lithium therapy varies across strategies.
  • Established methods exist for managing common and severe adverse effects.
  • Emerging research explores the use of sub-therapeutic lithium doses.
  • Limited evidence supports gradual titration, variable dosing, and enhanced monitoring.

Conclusions:

  • Optimizing lithium therapy is complex and requires prioritizing individual patient characteristics.
  • A key principle is maintaining the lowest therapeutic lithium level for each patient.
  • Close monitoring of lithium levels and adverse effects, alongside careful titration, is crucial.